Danoff Jonathan R, Cuellar Derly O, O Jane, Strauch Robert J
Department of Orthopaedic Surgery, Columbia University Medical Center, New York.
J Wrist Surg. 2015 Feb;4(1):43-8. doi: 10.1055/s-0035-1544225.
Background The purpose of this study was to determine the current trends and common practices for the treatment of Kienböck disease at different stages. Question/Purpose To determine the current trends and common practices by hand surgeons for the treatment of Kienböck disease. Methods A survey with hypothetical Kienböck disease cases stratified by the Lichtman staging system was distributed to the American Society for Surgery of the Hand (ASSH) members. Questions and responses reflected common treatment strategies. Results Of a total of 375 worldwide respondents, preferred treatments of Kienböck disease were as follows: for Stage I disease, an initial trial of splinting was favored (74%), followed by radial shortening osteotomy for continued symptoms. For Stage II disease, 63% of surgeons preferred surgical intervention, particularly radial shortening osteotomy. For Stage IIIa with negative ulnar variance, 69% chose radial shortening osteotomy. Responses were heterogeneous for Stage IIIa Kienböck with positive variance, and capitate shortening osteotomy and vascularized bone grafting were preferred. Salvage procedures predominated for Stage IIIb disease, including proximal row carpectomy (PRC; 42%), intracarpal arthrodesis (21%), and total wrist fusion (10.7%). Similarly, Stage IV disease was treated by 87% of respondents by either PRC or wrist fusion. Without regard to stage of disease, 90% of participants reported using the same Lichtman staging to guide treatment and would also alter treatment strategy based upon ulnar variance. Conclusions Most respondents used Lichtman staging and ulnar variance to guide treatment decisions. Results indicate that the most common surgical treatments were radial shortening osteotomy for early disease and PRC in later stages. Level of Evidence Level IV, Economic/Decision Analysis.
背景 本研究的目的是确定不同阶段月骨无菌性坏死疾病的当前治疗趋势和常见做法。问题/目的 确定手外科医生治疗月骨无菌性坏死疾病的当前趋势和常见做法。方法 向美国手外科协会(ASSH)成员发放了一份根据利希特曼分期系统分层的月骨无菌性坏死假设病例调查问卷。问题和回答反映了常见的治疗策略。结果 在全球375名受访者中,月骨无菌性坏死疾病的首选治疗方法如下:对于Ⅰ期疾病,首选初始夹板固定试验(74%),持续出现症状则采用桡骨缩短截骨术。对于Ⅱ期疾病,63%的外科医生倾向于手术干预,尤其是桡骨缩短截骨术。对于尺骨变异为阴性的Ⅲa期疾病,69%的医生选择桡骨缩短截骨术。对于尺骨变异为阳性的Ⅲa期月骨无菌性坏死疾病,回答存在异质性,头状骨缩短截骨术和带血管蒂骨移植术更受青睐。Ⅲb期疾病以挽救性手术为主,包括近排腕骨切除术(PRC;42%)、腕骨间融合术(21%)和全腕关节融合术(10.7%)。同样,87%的受访者对Ⅳ期疾病采用PRC或腕关节融合术进行治疗。不考虑疾病阶段,90%的参与者报告使用相同的利希特曼分期来指导治疗,并且也会根据尺骨变异改变治疗策略。结论 大多数受访者使用利希特曼分期和尺骨变异来指导治疗决策。结果表明,最常见的手术治疗方法是早期疾病采用桡骨缩短截骨术,后期采用PRC。证据级别 Ⅳ级,经济/决策分析。